MIM Pharma team is composed of experienced biopharma executives with a drive for transfer the legacy of deep-rooted-natural medicine to the modern pharmaceutical R&D and manufacturing techniques for introducing novel medical solutions for common annoying diseases such as Covid-19, migraine, and migraine-related diseases. The research and development team have achieved very promising results in treating these diseases. MIM Pharma management combines a wealth of talent and international experience in drug discovery and commercialization.